ArticleJapanese journal of radiology2025
Clinical significance of splenic switch-off in adenosine triphosphate
Article in Japanese journal of radiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnosis of multivessel coronary artery disease usingJapanese journal of radiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeSplenic switch-off (SSO) is defined as a decrease in splenic radiotracer uptake following pharmacological stress. This study aimed to assess the clinical utility of SSO on adenosine triphosphate (ATP) MATERIALS AND
methodsWe analyzed 63 patients (mean age, 67 ± 11 years; 34 males) who underwent ATP
resultsNegative SSO was observed in 15 of 63 patients. Global MFR and global stress MBF were significantly higher in the positive SSO group than in the negative SSO group (2.4 ± 0.6 vs. 1.6 ± 0.6, P < 0.001, and 2.3 ± 0.5 vs. 1.5 ± 0.5 ml min
conclusionsThe presence of a splenic response based on the visual assessment of SSO may be used to identify an adequate pharmacological response. This can affect the diagnosis of CMD in patients with reduced MFR without CAD. This study showed the clinical utility of splenic switch-off in adenosine triphosphate
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.